Ignite Creation Date:
2024-05-05 @ 11:56 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00188045
Status:
TERMINATED
Last Update Posted:
2017-11-01
First Post:
2005-09-12
Brief Title:
Hemodynamic Effects of Chronic Administration of Spironolactone andor Propranolol in Alcoholic Cirrhotic Patients
Sponsor:
University Hospital Angers
Organization:
University Hospital Angers
Study Overview
Official Title:
Hemodynamic Effects of Chronic Administration of Spironolactone Propranolol and Their Association in Alcoholic Cirrhotic Patients
Status:
TERMINATED
Status Verified Date:
2001-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of this study was assesment of splanchnic and systemic hemodynamic effects of chronic administration 2 month of spironolactone or propranolol alone or in association in alcoholic cirrhotic patients The patients were randomized in 4 groups aldactone 150 mgday propranolol 160 mgday aldactone 150 mgday propranolol 160 mgday placebo Systemic and splanchnic hemodynamic effect were evaluated by hepatic venous pressure gradient measurements before and after 2 month of treatment
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None